TAGLN2 promotes mesenchymal circulating tumor cell-associated metastasis through the CSNK1E-YAP Axis with concomitant EMT induction and metabolic remodeling in hepatocellular carcinoma.
Postoperative recurrence and hematogenous metastasis remain major barriers to long-term survival in hepatocellular carcinoma (HCC). Mesenchymal circulating tumor cells (mCTCs) are closely associated with HCC recurrence and metastasis, yet the key regulatory mechanisms and accompanying circulating metabolic alterations...